AAPG: Nilai perusahaan marang bathi resik Ascentage Pharma Group International

Ascentage Pharma Group International - logo grafis emiten AAPG

The high profitability of Ascentage Pharma Group is based on the optimization of biomaterial delivery and supply chain control. The company's P/E ratio clearly demonstrates the balance between actual earnings and market expectations, where -3.70 represents the current level of the metric. However, expansion by global behemoths is creating pressure, forcing the company to seek strategic partners for survival and the development of innovative methods to combat resistant tumors.

Koefisien rega marang bathi: Ascentage Pharma Group (AAPG) kanggo 25.01.2025 - 12.11.2026

Rincian metrik komprehensif lan analitis Ascentage (AAPG)

- rega saham lan prakiraan rega para ahli:
Bagan owah-owahan rega ascentage.com|AAPG - Target konsensus
- informasi kapitalisasi pasar:
Nilai pasar Ascentage Pharma Group|AAPG - Nilai Perusahaan
- indikator nilai aset resik miturut neraca:
Nilai Akuntansi saben Saham Ascentage Pharma|AAPG - Aset Bersih Perusahaan|Rasio Kapitalisasi Pasar marang Nilai Buku ascentage.com|AAPG - Aset Agregat Perusahaan
- informasi babagan utang lan solvabilitas:
Rasio Kabeh Utang marang Dana Pribadi Ascentage Pharma Group|AAPG - Utang jangka dawa marang modal|Kewajiban jangka cendhak marang modal Ascentage Pharma Corp|AAPG - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Ascentage Pharma Group|AAPG - Utang jangka dawa perusahaan|Gunggunge utang jangka cendhak Ascentage Pharma|Indikator likuiditas cepet ascentage.com
- indikator profitabilitas perusahaan lan kelipatan valuasi:
AAPG - Bathi resik|Bathi resik sing dikarepake Ascentage Pharma Group|AAPG - Rasio rega marang bathi|Rasio rega marang bathi mangsa ngarep Ascentage Pharma Group International|AAPG - Pangali rega marang bathi tumrap wutah|Koefisien nilai perusahaan marang bathi operasional sadurunge panyusutan Ascentage Pharma Group|AAPG - Bathi operasional EBITDA|Bathi resik saben saham (EPS TTM) Ascentage Pharma|AAPG - Bathi resik saben saham (EPS TTM)|Wutah bathi resik saben saham sajroning taun lumaku ascentage.com|AAPG - Wutah bathi ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun ngarep Ascentage Pharma Group
Ringkesan analisis perusahaan:AAPG, ascentage.com
Barang unggulan Ascentage Pharma

The expansion of international trials for leukemia drugs by Ascentage Pharma Group (AAPG) drives the current price-to-earnings ratio dynamics, reflecting market expectations for operating cash flow. This ratio measures the cost per unit of net profit, allowing investors to determine the asset's degree of overheating through mathematical rebalancing and mitigate capital risks in a timely manner, considering the R&D costs already priced in.

Analisis perusahaan pesaing

ONC: Nilai perusahaan marang bathi resik|Koefisien rega marang bathi HALO (Halozyme)|RVMD (Revolution Medicines Inc) - Nilai perusahaan marang bathi resik|Pangali P/E CGON (CG Oncology Corp)|URGN - Koefisien rega marang bathi|BCAX: Koefisien rega marang bathi|PSNL - Pangali P/E|Erasca (ERAS) - Rasio rega marang bathi|Delcath Systems Inc - Nilai perusahaan marang bathi resik|YMAB (YmAbs) - Pangali P/E|Kapitalisasi marang bathi Aura Corp AURA|Pangali P/E CADL|Pangali P/E accuray.com (ARAY)|Rasio rega marang bathi SELLAS Life Sciences Group SLS|Periode bali modal bisnis Actuate Therapeutics Inc. (ACTU)|Citius Oncology, Inc - Pangali P/E|TuHURA Biosciences, Inc. (HURA) - Koefisien rega marang bathi|TARA: Pangali P/E|Kapitalisasi marang bathi fatetherapeutics.com (FATE)|Rasio rega marang bathi Aadi Bioscience, Inc.|Pangali rega marang bathi TCRX (TScan)|Koefisien rega marang bathi CSBR (Champions Oncology)|Rasio rega pasar marang bathi resik XBIT|Pangali P/E CVM (CEL-SCI)|Pangali P/E ostherapies.com OSTX|Radiopharm Theranostics - Pangali P/E|Rasio kapitalisasi marang bathi resik Artiva Biotherapeutics, Inc. (ARTV)|ANL: Pangali P/E|Kapitalisasi marang bathi Veru Corporation (VERU)|Koefisien rega marang bathi TPST|XLO: Nilai perusahaan marang bathi resik|Rasio rega marang bathi Renovaro Inc. (RENB)|MURA: Kapitalisasi marang bathi resik|Pangali P/E KAPA (Kairos Pharma)|Nilai perusahaan marang bathi resik OKUR|CytoMed - Pangali P/E|CRIS - Pangali P/E|apollomicsinc.com (APLM) - Rasio rega marang bathi|Tharimmune Inc - Nilai perusahaan marang bathi resik|Rasio rega marang bathi Advanced Biomed Inc.|Koefisien rega marang bathi Genprex Inc (GNPX)|Pangali P/E CLDI|Pangali P/E sunshinebiopharma.com (SBFM)|Xenetic Biosciences, Inc. - Koefisien rega marang bathi|Nilai perusahaan marang bathi resik SLRX|Purple Biotech Corp - Pangali P/E|Rasio kapitalisasi marang bathi resik American Oncology Network (AONC)|BeiGene, Ltd. (BGNE) - Rasio rega marang bathi|checkpointtx.com - Nilai perusahaan marang bathi resik|Rasio rega marang bathi Elevation Oncology|Kapitalisasi marang bathi iCAD Corp ICAD|Koefisien rega marang bathi IKNA (Ikena Oncology, Inc.)|Pangali P/E Notable Labs Corp (NTBL)|Rasio rega marang bathi Viracta Therapeutics, Inc. VIRX|MOR (morphosys.com) - Kapitalisasi marang bathi resik|NAYA Biosciences Inc. - Pangali P/E|AAPGV - Pangali P/E